Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/19/24
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 04/28/25
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 04/12/23
End: 01/05/24
Due: 01/05/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects | NCT06527677 | Antabio | user2@example.com | None | 2024-07-19 | 2025-08-31 | 2026-08-31 | - | - | 2025-07-14 |
| Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants | NCT06916156 | Antabio | user2@example.com | None | 2025-04-28 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |
| FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects | NCT05905913 | Antabio | user2@example.com | None | 2023-04-12 | 2024-01-05 | 2025-01-05 | - | - | 2025-07-14 |